Page 111 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon
P. 111

1522_C02.fm  Page 96  Wednesday, November 12, 2003  9:36 AM










                                                                                298  367 494  491
                                                   271   446  312          324                   528
                                             450
                                       Norm.
                                    2000000
                                          Abundance                               IS







                                         0
                                               3.5      4.0      4.5     5.0      5.5      6.0  Time (min)

                                    Figure 2.11  Merged mass chromatogram of glisoxepide (m/z 450), tolbutamide
                                    (m/z 271), glipizide (m/z 446), tolazamide (m/z 312), gliclazide (m/z 324), trimi-
                                    pramine (IS, m/z 298), glibornuride (m/z 367), glibenclamide (m/z 494), glimepir-
                                    ide (m/z 491), and gliquidone (m/z 528). (Reprinted from Maurer H.H., Kratzsch,
                                    Kraemer T., Peters F.T., and Weber A.W., Screening, library-assisted identification
                                    and validated quantification of oral antidiabetics of the sulfonylurea-type in
                                    plasma by atmospheric pressure chemical ionization liquid chromatography-mass
                                    spectrometry. J. Chromatogr. B 773, 63, 2002. Copyright 2002, with permission
                                    from Elsevier Science.)


                                    2.4.2.1  Oral Antidiabetic Drugs
                                               138
                                    Ramos et al.  published a fast LC/APCI/MS/MS method for determina-
                                    tion of glibenclamide in human plasma after acetonitrile precipitation,
                                    using deuterated analog as internal standard. The retention time of drug
                                    was 3 min, the LOQ 1  mg/l. Sulfonylurea antidiabetics (tolbutamide,
                                    chlorpropamide, glibenclamide, and glipizide) were detected and quanti-
                                                                139
                                    fied in serum using LC/ESI/MS.  SPE method applied (on C18 cartridges)
                                    gave much cleaner extracts than acidic toluene extraction. The drugs were
                                    separated in methanol–acetic acid gradient and detected by ESI-MS in full
                                    scan mode (positive ions, m/z 265 to 510). For quantitation, protonated
                                    quasi-molecular ions were used. The LOQ was 10 mg/l for all drugs. Maurer
                                         140
                                    et al.  published a LC/APCI/MS procedure for screening and library-
                                    assisted quantification of antidiabetics glibenclamide, glibornuride, gli-
                                    clazide, glimepiride, glipizide, gliquidone, glisoxepide, tolazamide and
                                    tolbutamide. The drugs were extracted from plasma with ether–ethyl ace-
                                    tate and separated on Select B column in gradient elution conditions.
                                    Protonated quasi-molecular ions were used for screening and quantifica-
                                    tion, and full scan spectra for identification. Limits of detection varied
                                    from 2 to 3000 mg/l.


                                    © 2004 by CRC Press LLC
   106   107   108   109   110   111   112   113   114   115   116